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What is already known about this subject? 
• Human body weight is believed to be regulated by feedback control of both 
energy intake and energy expenditure. 
• Adaptations of energy expenditure to weight loss have been well-established, but 
the feedback control of energy intake has yet to be quantified. 
• SGLT2 inhibition provides a unique means of covertly inducing negative energy 
balance without directly influencing expenditure or central pathways regulating 
food intake. 
 
What this study adds: 
• We provide the first quantification of the feedback control of energy intake in 
free-living humans.  
• The increase in energy intake per kg of weight lost is several-fold larger than the 
known energy expenditure adaptations.   
• Feedback control of energy intake is likely the primary reason why it is difficult 
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Objective: To quantify the feedback control of energy intake in response to long-term 
covert manipulation of energy balance in free-living humans.  
Methods: We used a validated mathematical method to calculate energy intake changes 
during a 52 week placebo-controlled trial in 153 patients treated with canagliflozin, a 
sodium glucose co-transporter inhibitor that increases urinary glucose excretion thereby 
resulting in weight loss without patients being directly aware of the energy deficit. We 
analyzed the relationship between the body weight time course and the calculated energy 
intake changes using principles from engineering control theory. 
Results: We discovered that weight loss leads to a proportional increase in appetite 
resulting in eating above baseline by ~100 kcal/day per kg of lost weight – an amount 
more than 3-fold larger than the corresponding energy expenditure adaptations.  
Conclusions: While energy expenditure adaptations are often thought to be the main 
reason for slowing of weight loss and subsequent regain, feedback control of energy 
intake plays an even larger role and helps explain why long-term maintenance of a 
reduced body weight is so difficult.  
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Body weight is believed to be regulated by feedback control of both energy intake and 
energy expenditure. Several experiments in humans have quantified how energy 
expenditure adapts in response to alterations of energy intake and body weight. For 
example, Leibel and colleagues found energy expenditure adaptations of several 
hundreds of kcal/day acting to resist weight loss (1). In contrast, energy intake 
adaptations have yet to be accurately quantified in humans despite the widespread belief 
that feedback control of energy intake is critical for body weight regulation and acts as 
part of a complex neurobiological system to determine overall human food intake 
behavior (2). 
 
Why has the assessment of human energy intake feedback control lagged the 
quantification of energy expenditure changes with weight loss? First, we lacked the 
ability to accurately measure changes in free-living energy intake in large numbers of 
people over extended time periods. While accurate energy intake measurements can be 
performed while subjects are housed in laboratory setting, such studies are typically of 
short duration and the artificial nature of the environment makes it difficult to translate 
the results to the real world (3). Indeed, free-living energy intake is known to fluctuate 
widely from day to day and exhibits little short-term correlation with energy expenditure 
or body weight (4). Therefore, observations over long time scales are required thereby 
making laboratory based studies impractical.  
 
Unfortunately, free-living subjects are notorious for being unable to provide accurate 
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estimates of energy intake using self-report methods (5) and the expense and difficulty of 
employing objective biomarker methods severely limits their applicability. To address 
this important problem, we recently validated an inexpensive mathematical method for 
calculating energy intake changes using repeated body weight data in 140 free-living 
subjects over a two year calorie restriction study and found that the mean calculated 
energy intake changes were within 40 kcal/day of those determined using an expensive 
biomarker method (6).  
 
The second impediment to quantifying energy intake control in humans is that we lacked 
an intervention that increases energy output by a known amount without participants 
consciously knowing that this is occurring. Rather, most interventions that alter body 
weight or energy expenditure also evoke cognitive responses that may mask the effect of 
weight changes per se on the feedback control of energy intake. For example, engaging in 
an exercise program might increase energy expenditure and lead to weight loss, but 
exercise is a conscious behavior that doesn’t have an effective placebo control. 
Furthermore, exercise has a complex role in modulating appetite (7) and may induce 
compensatory changes in other components of total energy expenditure that are difficult 
to quantify. Therefore, changes in energy intake during an exercise program may not 
solely be due to feedback mechanisms controlling body weight, but are likely to also 
involve conscious changes in behavior. 
 
Here, we used data from a placebo-controlled trial in patients with type 2 diabetes who 
were treated for one year with canagliflozin, an inhibitor of sodium glucose transporter 2 
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(SGLT2), thereby increasing energy output in the form of urinary glucose excretion 
(UGE) (8).  In patients with type 2 diabetes, treatment with canagliflozin at a dose of 300 
mg/day increases mean daily UGE by approximately 90 g/day which is sustained at the 
same level throughout the duration of treatment (9) without directly altering energy 
expenditure (10, 11) or central pathways controlling energy intake and without the 
patients being directly aware of the energy deficit. In other words, SGLT2 inhibition 
provides a novel way to covertly perturb human energy balance that largely bypasses the 
volition and conscious awareness of the subjects. Any observed increased energy intake 
countering the weight loss induced by SGLT2 inhibition therefore likely reflects the 
activity of the feedback control system.  
 
We calculated the free-living energy intake changes in 153 patients treated with 300 
mg/day canagliflozin over a 52 week trial using the measured body weight data and an 
assumed mean UGE of 90 g/day as inputs to a mathematical model that has recently been 
validated against an expensive biomarker method (6). We found that the feedback control 
of energy intake in humans was proportional to the amount of weight lost and was 
substantially stronger than the control of energy expenditure.  
 
Methods 
Calculating changes in energy intake during canagliflozin treatment 
We used measured body weight, BW, and baseline patient characteristics in the 
previously published placebo-controlled trail of canagliflozin (8). We calculated the 
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changes in energy intake, ΔEI, for each subject using a validated mathematical method 















∆ = + − + +
−
 (Equation 1) 
 
The inputs to the model were the change of body weight versus baseline over each 
interval, ( )0iBW BW− , and the moving average of the measured body weight time course 
was used to calculate the rate of change of body weight over each interval, dBWi/dt. The 
interval length was t = (N-1)*T, where N = 2 was the number of body weight 
measurements per interval and T = 52 was the number of days between measurements. 
Three subjects treated canagliflozin and 2 subjects treated with placebo had missing body 
weight data at one time point and linear interpolation was used to impute the missing 
data.   
  
Equation 1 is a linearization of a mathematical model of adult body weight dynamics that 
was developed and validated using data obtained primarily from controlled feeding 
studies in adult humans with longitudinal measurements of changes in body composition 
as well as both resting and total energy expenditure (12, 13, 14). The model parameter ρ 
was the effective energy density associated with the body weight change:  
 
( )( )1 1





  (Equation 2) 
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and ε defined how energy expenditure depends on body weight: 
  








= + + ∆ 
− + 
  (Equation 3). 
 
The model parameters γFFM and γFM are the regression coefficients relating resting 
metabolic rate to fat-free mass (FFM) and fat mass (FM), respectively. Parameters ρFM 
and ρFFM are the energy densities associated with changes in FM and FFM, respectively. 
Most physical activities involve locomotion and have an energy cost that is proportional 
to body weight for a given intensity and duration of activity. The baseline physical 
activity parameter was δ0 and ∆δ represents changes in physical activity that can be 
informed by objective measurements, if available. Without such measurements, physical 
activity changes are often assumed to be zero (∆δ=0) with the realization that the 
calculated energy intake changes may be in error, especially at the individual level where 
substantial physical activity changes can occur throughout a study. Averaging over many 
individuals with the  assumption that ∆δ=0 can also result in a biased mean energy intake 
change of the group, but our previous validation study demonstrated that this bias is 
likely to be <40 kcal/day when studying >100 individuals (6).  
 
The parameter β accounts for the adaptation of energy expenditure during a diet 
perturbation, ∆EI, and was determined using data from eight human studies that 
measured changes in body composition as well as both total and resting energy 
expenditure before and after achieving a period of long-term stability at a lower weight. 
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Parameters FMη  and FFMη  account for the biochemical cost of tissue deposition and 
turnover assuming that the change of FFM is primarily accounted for by body protein and 
its associated water.  
 
The parameter α  represents the relationship between changes of lean and fat mass: 
dFFM dFM C FMα ≡ =  where C = 10.4 kg is the Forbes parameter. This simple 
model of body composition change provides accurate predictions that have been 
demonstrated to be consistent across different ethnic groups and sexes (15). For modest 
weight changes, α  can be considered to be approximately constant with FM fixed at its 
initial value FM0. The larger the initial fat mass, FM0, the smaller the parameter α, as 
previously described (14). The parameter UGE represents the energy losses as a result of 
increased urinary excretion of glucose with canagliflozin treatment. Model parameter 
values are given in Table 1.  
 
In addition to validating our mathematical model using body composition and energy 
expenditure data from controlled feeding studies (12, 13, 14), the model has also 
demonstrated accurate weight loss predictions regardless of medication usage or 
comorbid conditions, including type 2 diabetes, in free-living individuals with obesity 
following reduced calorie diets (16). 
 
Modeling feedback control of energy intake 
While many hormonal and neuronal factors are known to be involved in the regulation of 
food intake (2), general properties of the feedback relationship between changes in body 
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weight and changes in energy intake have not been well characterized or quantified. We 
tested the ability of two potential feedback models to describe the observed body weight 
profiles in response to sustained canagliflozin treatment. 
  
In the first model, referred to as “proportional control”, changes in the signals regulating 
food intake depend only on the current body weight and are not dependent on the 
duration or rate of weight loss.  In this model, the aggregate effect of different feedback 
signals regulating body weight are described by the equation:  
 
            
( ) ( )PEI t k BW t∆ = − ×∆   (Equation 4)                        
 
where the parameter kP >0 quantifies the feedback strength. To simulate how 
proportional control of energy intake affects body weight kinetics during canagliflozin 
treatment, we added a UGE term to a validated mathematical model of adult human body 
weight dynamics (14) and calculated the mean ∆EI time course during placebo treatment 
to capture the typical transient weight loss effect of being in the trial (see Figure 1). 
Equation 4 was then added to the placebo energy intake to simulate the mean 
proportional control of ∆EI during canagliflozin treatment. The best fit parameter kP was 
determined by a downhill simplex algorithm  implemented using Berkeley Madonna 
software (version 8.3; http://www.berkeleymadonna.com) to minimize the sum of squares 
residuals between the simulation outputs and the measured mean body weight and the 
calculated mean ∆EI. 
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We also investigated another possible model for body weight regulation that was 
previously suggested (17) such that changes in energy intake also depend on how long 
body weight has deviated from baseline, which is expressed as an integral term quantified 
by a parameter kI >0:  
( ) ( ) ( )
0
t
P IEI t k BW t k BW dτ τ∆ = − ×∆ − ∆∫
   (Equation 5) 
The integral feedback control was simulated using Equation 5 with the best fit value of kP 
from Equation 4 and kI = 1 kcal/kg/d
2
.   
 
Results  
Table 2 represents the characteristics of the type 2 diabetic subjects who completed the 
52 week study and had body weight measurements throughout. The full study cohort was 
previously reported (8). In response to the sustained increase in UGE with canagliflozin 
treatment, mean body weight declined and reached a new equilibrium several kilograms 
lower and significantly more than the placebo group whose mean body weight loss was 
less than 1 kg (Figure 1A). To explain the measured body weight changes in the 
treatment group given the estimated increases in UGE, energy intake was calculated to 
have increased by ~350 kcal/day at steady state (Figure 1B) which is similar to recent 
estimates of the mean energy intake changes during 90 weeks of empagliflozin treatment, 
another SGLT2 inhibitor (18). In the placebo group, mean energy intake was calculated 
to transiently decrease by ~100 kcal/day over the first several weeks and return to 
baseline after 15 weeks (Figure 1B) 
 
Note that as body weight declined during SGLT2 inhibition, energy intake increased 
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above baseline until it compensated for the loss of calories via UGE, after which, a new 
equilibrium was reached.  This general pattern of response, in which a sustained 
perturbation (caloric loss via UGE) leads to a new equilibrium at a lower body weight, 
suggests that the endocrine signals responding to weight loss (such as leptin) act as part 
of a proportional feedback control system as shown in the curves depicted in Figure 2 
illustrating that proportional feedback control (as defined by Equation 4 with the 
parameter kP = 95 kcal/day per kg) mimics the observed body weight and energy intake 
patterns in humans receiving SGLT2 inhibitors.  
 
In contrast, despite the persistent increase in UGE, if the system regulating body weight 
included integral feedback control (Equation 5), body weight would ultimately have been 
restored to baseline values even in the presence of sustained increases in UGE. This 
outcome is a well-known result from control theory that integral feedback is a necessary 
and sufficient condition for a system to produce zero steady-state error (i.e., return to 
baseline body weight) in response to a sustained perturbation (i.e., persistently increased 
UGE) and that a proportional feedback system will always have a non-zero steady-state 
error (i.e., a sustained reduction in body weight) in response to a sustained perturbation.   
In contrast, for any value of kI > 0, a system including integral feedback in the regulation 
of energy intake would have only transient weight loss during sustained SGLT2 inhibitor 
treatment as shown for the integral feedback model in Figure 2. 
 
By modeling the mean changes in energy intake obtained with SGLT2 inhibitor treatment 
using the proportional feedback model, our results quantify the strength of energy intake 
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feedback control in humans. On average, energy intake increased by ~100 kcal/day per 
kg of weight lost—an effect substantially greater than the ~30 kcal/kg/day changes in 
energy expenditure observed with 10 to 20% weight loss in subjects with obesity (1).  
 
To illustrate the importance of our results for obesity treatment, consider the body weight 
trajectory depicted in Figure 3A that resulted from long-term participation in a structured 
commercial weight loss program (19) and illustrates the ubiquitous body weight time 
course characterized by initial weight loss, a plateau after 6-8 months, followed by slow 
weight regain (20). The calculated energy intake corresponding to this mean body weight 
trajectory is illustrated in Figure 3B showing an initial reduction of ~700 kcal/day from 
baseline followed by an exponential relaxation towards baseline intake over the ensuing 
months. The estimated energy expenditure corresponding to this intervention is also 
shown in Figure 3B and indicates relatively minor changes in comparison to the changes 
in energy intake.  
 
Note that at the point of maximum weight loss occurring at the ~8 month plateau, energy 
intake had already returned to within 100 kcal/day of baseline. After 1 year, the average 
energy intake was practically at baseline levels while body weight was still reduced by ~5 
kg. A similar pattern of relapsing diet adherence has been observed using objective 
biomarker methods during an intensive 2 year calorie restriction study where calorie 
intake was much lower during the early period of weight loss than after the body weight 
had plateaued (6, 21).  
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The calculated energy intake time course during the lifestyle intervention suggests that 
diet adherence lapsed very early with subjects returning to their previous caloric intake 
and a corresponding weight plateau followed by slow weight regain. While this might be 
interpreted as indicating that the participants rapidly decreased their efforts to adhere to 
the intervention, it is enlightening to consider their food intake behavior within the 
context of the proportional feedback control system. The dashed curve in Figure 3B 
illustrates the energy intake pattern corresponding to the increased appetite in response to 
the feedback signals arising from the body weight changes shown in Figure 3A. The 
difference between the increased appetite and the actual energy intake is depicted in 
Figure 3C and is a quantitative index of the ongoing effort to sustain the intervention in 
the face of the continuing biological signals to overeat. In this context, a substantial 
persistent effort is required to avoid overeating above baseline to satisfy the increased 
appetite during the intervention despite the average energy intake returning to near 
baseline levels.  
 
Discussion 
In the absence of ongoing efforts to restrain food intake following weight loss, feedback 
control of energy intake will result in eating above baseline levels with an accompanying 
acceleration of weight regain. Such behavior has been previously observed in rodent 
models when a return to ad libitum feeding following diet restriction resulted in 
hyperphagia until the lost weight was regained (22). This phenomenon has been also 
observed in lean men following experimental semi-starvation (23) or short-term 
underfeeding (24, 25, 26). Hyperphagia in these studies was believed to result from 
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homeostatic signals arising from loss of both body fat and lean tissues (27, 28), but a 
conscious desire to regain lost weight cannot be ruled out and may have contributed to 
increased food intake. 
 
Previous studies of energy intake regulation in humans have employed short-term diet 
manipulations to measure compensatory changes in energy intake (29, 30, 31, 32). While 
such studies can provide useful information about the influence of episodic appetite 
signals on short-term modulation of energy intake, the results cannot be readily 
extrapolated to the long time scales associated with regulation of human energy balance 
and do not provide information about how weight changes influence energy intake.   
 
Long-term inhibition of SGLT2 provides a unique probe for assessment of human energy 
homeostasis since the mechanism of action is clear, its effect on energy output is 
consistent, and the intervention is unlikely to directly affect central pathways involved in 
regulation of food intake. In contrast, other interventions aimed at increasing energy 
expenditure, such as exercise (7) or exogenous delivery of thyroid hormone (33), have 
pleiotropic effects and their impact on energy expenditure can be highly variable.    
 
The suggestion that the signals controlling energy intake act as a proportional feedback 
system without integral feedback is consistent with the roughly proportional changes in 
appetite-regulating hormones that occur rapidly in response to weight loss and do not 
further increase as weight loss is sustained (as would occur with integral feedback) (34). 
We do not yet know whether the simple proportional controller represented by Equation 
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4 is valid for a range of weight losses. For example, it may be possible that small weight 
changes are uncompensated by changes in energy intake such that the control system 
engages only after sufficient weight loss to cross some threshold (35). Furthermore, 
larger weight losses may result in energy intake adaptations corresponding to a nonlinear 
function of body weight change. Future research is required to address these questions 
and more fully characterize the energy intake feedback control system, characterize its 
variability between individuals, and identify its physiological mediators in humans.  
 
Proportional feedback control of energy intake may help explain why the calculated 
exponential decay of diet adherence during weight loss interventions markedly contrasts 
with self-reported measurements that indicate persistence of diet adherence and no 
significant differences in caloric consumption between the period of early weight loss 
compared with the later time when weight has plateaued (36). This has led to speculation 
that the 6-8 month weight plateau may be entirely due to slowing of metabolic rate rather 
than loss of diet adherence. Our results suggest otherwise and further illustrate that self-
reported energy intake measurements are quantitatively unreliable (5). Nevertheless, the 
relative constancy self-reported energy intake over the first 6 months corresponds well 
with the calculated persistent effort to resist the increased appetite and the drive to 
overeat at above baseline levels. Therefore, self-reported measurements of diet may more 
accurately reflect the perceived effort of the dieter to adhere to the intervention rather 
than their actual energy intake.   
 
An important limitation of our study is that we did not have direct measurements of 
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energy expenditure following SGLT2 inhibition. Rather, we calculated the expected 
energy expenditure changes using our mathematical model that was previously validated 
to accurately simulate the response to weight changes resulting from controlled changes 
in energy intake (12, 13, 14). Therefore, the calculated energy intake changes assumed 
that SGLT2 inhibition did not directly influence energy expenditure which is consistent 
with data from a 4 week study in humans showing no significant changes in pre- or post-
meal energy expenditure after 4 weeks of treatment with the SGLT2 inhibitor 
empagliflozin (10) and data showing no significant changes in oxygen consumption in 
rodents treated with canagliflozin (11).  
 
We restricted our analysis to the group mean rather than attempt to characterize 
individual responses since UGE was not directly measured in each subject but was 
assumed to be ~90 g/day based on previous measurements in people with type 2 diabetes 
treated with 300 mg/day canagliflozin (9, 37, 38). A subset of subjects in this study 
underwent a meal tolerance test where UGE was measured; their mean increase in UGE 
over the 3h meal test was 14.7 g (39); this is similar to the value observed following 
meals in other studies where mean 24h UGE was measured to be ~90 g/day and suggests 
that the mean daily UGE in this study is unlikely to be substantially different than what 
was assumed. Therefore, there is a correspondingly small uncertainty in the mean 
calculated proportional control of energy intake (~100 kcal/day per kg of body weight 
lost) at the group level. Measuring daily UGE in individuals during long-term studies 
with SGLT2 inhibitors would enable the individual subject variability in the magnitude of 
the compensatory energy intake responses to be characterized.   
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In summary, our results provide the first quantification of the energy intake feedback 
control system in free-living humans. We found that appetite increased by ~100 kcal/day 
above baseline per kilogram of lost weight – an effect several-fold larger than the 
corresponding energy expenditure adaptations. The few who successfully maintain 
weight loss over the long term do so by heroic and vigilant efforts to maintain behavior 
changes in the face of increased appetite along with persistent suppression of energy 
expenditure (40) in an omnipresent obesogenic environment. Permanently subverting or 
countering this feedback control system poses a major challenge for the development of 
effective obesity therapies.  
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Parameter Value Description 
FMγ   
3.2 kcal/kg/d Energy expenditure rate of fat mass 
FFMγ   
22 kcal/kg/d Energy expenditure rate of fat free mass 
δ0 10 kcal/kg/d Physical activity at baseline 
∆δ 0 kcal/kg/d Physical activity changes 
FMη   
180 kcal/kg Energy cost of fat turnover 
FFMη   
230 kcal/kg Energy cost of protein turnover 
FMρ   
9300 kcal/kg Energy density of fat mass 
FFMρ   1100 kcal/kg Energy density of fat free mass 
β   0.24 Dietary and adaptive thermogenesis 
UGE 360 kcal/d Energy loss due to increased urinary 
glucose excretion with canagliflozin 
(300 mg/d)  
Table 1. Mathematical model parameters. 
  
Page 24 of 30
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Obesity














(n = 89) 
Canagliflozin 
(n = 153) 
Sex, n (%)     
Male 47 (53) 66 (43) 




Waist circumference (cm) 
57 ± 10 
88 ± 18 
32 ± 6 
106 ± 13 
55 ± 11 
87 ± 21 
32 ± 6 
105 ± 15 
Race, n (%)     
White 62 (70) 106 (69) 
Black or African American 2 (2) 7 (5) 
Asian 15 (17) 24 (16) 
Other
†
 10 (11) 16 (10) 
HbA1c (%) 7.5 ± 0.6 7.9 ± 0.8 
Fasting plasma glucose (mmol/L) 8.2 ± 2.1 9.3 ± 2.4 
Diabetes duration (y) 3 ± 4 3 ± 4 
eGFR (mL/min/1.73m2) 85 ± 21 88 ± 19 
 
Table 2. Baseline characteristics of the study subjects. Data are mean ± SD unless 
otherwise indicated. 
†
 Includes American Indian or Alaska Native, Native Hawaiian or 
other Pacific Islander, multiple, other or not reported 
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Figure 1. Body weight and energy intake changes during placebo and SGLT2 inhibition. 
(A) Average body weight measurements in the placebo group () and SGLT2 inhibition 
group () along with mathematical model simulations depicted as dashed and solid 
curves, respectively. (B). Calculated energy intake changes in the placebo group () and 
the SGLT2 inhibitor group () along with the mathematical model simulations (curves).  
Mean ± 95% CI. 
Figure 2. Characterization of feedback control of energy intake in subjects with type 2 
diabetes treated with canagliflozin (8). (A) Observed changes in body weight (■) and the 
simulated changes with proportional control (solid curve) or integral control (dashed 
curve) of energy intake. (B) Calculated changes in energy intake () and the simulated 
changes with or proportional control (solid curve) integral control (dashed curve) of 
energy intake. Mean ± 95% CI. 
Figure 3. Energy balance dynamics during a lifestyle intervention for weight loss (19). 
(A) Average body weight (■) typically decreases and reaches a plateau after 6-8 months 
of a lifestyle intervention followed by slow weight regain. (B) Energy expenditure 
changes relatively little during the intervention (dotted curve) whereas energy intake 
(solid curve) initially drops by a large amount followed by an exponential return towards 
baseline (thin horizontal gray line). The feedback from the body weight loss signals a 
large increase in appetite (dashed curve) that is resisted by the attempt to sustain the 
intervention. (C) The average effort during the intervention was defined as the difference 
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between the increased appetite and the actual energy intake. A substantial effort persists 
during the intervention despite a return to near baseline energy intake. Mean ± 95% CI. 
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